1. Medulloblastoma is the most common cause of brain cancer in children.2. Mutations in " PTCH1 " are also associated with medulloblastoma . 3. Remarkably, the treatment with CXCL3 reduces the area of medulloblastoma lesions. 4. Thus, CXCL3 is a potential target for medulloblastoma therapy. 5. Depletion of BRD3 slows growth in cancer models including prostate cancer and medulloblastoma . 6. Mice with mutations in mouse " PTCH1 " similarly develop medulloblastoma . 7. Characterization of the role of JPO proteins that are overexpressed in metastatic medulloblastoma . 8. Two prominent examples are pediatric neoplasms ( such as medulloblastoma ) and prostate cancer. 9. The most common cause of damage to the flocculonodular lobe is medulloblastoma in childhood. 10. Correct diagnosis of medulloblastoma may require ruling out atypical teratoid rhabdoid tumor ( ATRT)
